Nanosuspension-Loaded Dissolving Microneedle Patches for Enhanced Transdermal Delivery of a Highly Lipophilic Cannabidiol

References

• Paredes AJ, McKenna PE, Ramöller IK, et al. Microarray patches: poking a hole in the challenges faced when delivering poorly soluble drugs. Adv Funct Mater. 2020;31(1). doi:10.1002/adfm.202005792
   Web of Science ®Google Scholar
• Sengupta P, Chatterjee B. Potential and future scope of nanoemulgel formulation for topical delivery of lipophilic drugs. Int J Pharm. 2017;526(1–2):353–365. doi:10.1016/j.ijpharm.2017.04.068
   PubMed Web of Science ®Google Scholar
• Zhang LH, Zhu WF, Lin QS, Han J, Jiang LQ, Zhang YZ. Hydroxypropyl-β-cyclodextrin functionalized calcium carbonate microparticles as a potential carrier for enhancing oral delivery of water-insoluble drugs. Int J Nanomed. 2015;10:3291–3302. doi:10.2147/Ijn.S78814
   PubMed Web of Science ®Google Scholar
• Mbah CC, Builders PF, Attama AA. Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus. Expert Opin Drug Deliv. 2014;11(1):45–59. doi:10.1517/17425247.2013.860130
   PubMed Web of Science ®Google Scholar
• Chen H, Khemtong C, Yang X, Chang X, Gao J. Nanonization strategies for poorly water-soluble drugs. Drug Discovery Today. 2011;16(7–8):354–360. doi:10.1016/j.drudis.2010.02.009
   PubMed Web of Science ®Google Scholar
• Pandey RP, Vidic J, Mukherjee R, Chang CM. Experimental methods for the biological evaluation of nanoparticle-based drug delivery risks. Pharmaceutics. 2023;15(2). doi:10.3390/pharmaceutics15020612
   Web of Science ®Google Scholar
• Kalepu S, Nekkanti V. Insoluble drug delivery strategies: review of recent advances and business prospects. Acta Pharmaceutica Sinica B. 2015;5(5):442–453. doi:10.1016/j.apsb.2015.07.003
   PubMed Web of Science ®Google Scholar
• Bird D, Ravindra NM. Transdermal drug delivery and patches—An overview. Med Dev Sensors. 2020;3(6). doi:10.1002/mds3.10069
   Google Scholar
• Siavashy S, Soltani M, Ahmadi M, Landi B, Mehmanparast H, Ghorbani‐Bidkorbeh F. A comprehensive review of one decade of microfluidic platforms applications in synthesis of enhanced carriers utilized in controlled drug delivery. Adv Mater Technol. 2022;7(10). doi:10.1002/admt.202101615
   Web of Science ®Google Scholar
• Tijani AO, Thakur D, Mishra D, Frempong D, Chukwunyere UI, Puri A. Delivering therapeutic cannabinoids via skin: current state and future perspectives. J Control Release. 2021;334:427–451. doi:10.1016/j.jconrel.2021.05.005
   Web of Science ®Google Scholar
• Fu XL, Shi YB, Wang H, et al. Ethosomal gel for improving transdermal delivery of thymosin β-4. Int j Nanomed. 2019;14:9275–9284. doi:10.2147/Ijn.S228863
   PubMed Web of Science ®Google Scholar
• Li B, Lu G, Liu W, Liao L, Ban J, Lu Z. Formulation and evaluation of PLGA nanoparticulate-based microneedle system for potential treatment of neurological diseases. Int j Nanomed. 2023;18:3745–3760. doi:10.2147/ijn.S415728
   PubMed Web of Science ®Google Scholar
• Swain S, Beg S, Singh A, Patro CN, Rao MEB. Advanced techniques for penetration enhancement in transdermal drug delivery system. Curr Drug Deliv. 2011;8(4):456–473. doi:10.2174/156720111795767979
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Langer R. Transdermal drug delivery. Nature Biotechnol. 2008;26(11):1261–1268. doi:10.1038/nbt.1504
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhao M, Cao J, et al. Applications and recent advances in transdermal drug delivery systems for the treatment of rheumatoid arthritis. Acta Pharmaceutica Sinica B. 2023. doi:10.1016/j.apsb.2023.05.025
   Web of Science ®Google Scholar
• Funke AP, Günther C, Müller RH, Lipp R. Development of matrix patches for transdermal delivery of a highly lipophilic antiestrogen. Drug Dev Ind Pharm. 2003;29(7):785–793. doi:10.1081/ddc-120021778
   PubMed Web of Science ®Google Scholar
• Lee KJ, Jeong SS, Roh DH, Kim DY, Choi HK, Lee EH. A practical guide to the development of microneedle systems - In clinical trials or on the market. Int J Pharm. 2020;573:118778. doi:10.1016/j.ijpharm.2019.118778
   PubMed Web of Science ®Google Scholar
• Salwa, Chevala NT, Jitta SR, Marques SM, Vaz VM, Kumar L. Polymeric microneedles for transdermal delivery of nanoparticles: frontiers of formulation, sterility and stability aspects. J Drug Delivery Sci Technol. 2021;65. doi:10.1016/j.jddst.2021.102711
   Web of Science ®Google Scholar
• Karim Z, Karwa P, Hiremath SRR. Polymeric microneedles for transdermal drug delivery- A review of recent studies. J Drug Delivery Sci Technol. 2022;77. doi:10.1016/j.jddst.2022.103760
   Google Scholar
• Bauleth-Ramos T, El-Sayed N, Fontana F, Lobita M, Shahbazi M-A, Santos HA. Recent approaches for enhancing the performance of dissolving microneedles in drug delivery applications. Mater Today. 2023;63:239–287. doi:10.1016/j.mattod.2022.12.007
   Web of Science ®Google Scholar
• González-Vázquez P, Larrañeta E, McCrudden MTC, et al. Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis. J Control Release. 2017;265:30–40. doi:10.1016/j.jconrel.2017.07.032
   PubMed Web of Science ®Google Scholar
• Wu Y, Vora LK, Mishra D, et al. Nanosuspension-loaded dissolving bilayer microneedles for hydrophobic drug delivery to the posterior segment of the eye. Biomater Adv. 2022:137. doi:10.1016/j.bioadv.2022.212767
   Google Scholar
• Dangol M, Yang H, Li CG, et al. Innovative polymeric system (IPS) for solvent-free lipophilic drug transdermal delivery via dissolving microneedles. J Control Release. 2016;223:118–125. doi:10.1016/j.jconrel.2015.12.038
   PubMed Web of Science ®Google Scholar
• Al-Kassas R, Bansal M, Shaw J. Nanosizing techniques for improving bioavailability of drugs. J Control Release. 2017;260:202–212. doi:10.1016/j.jconrel.2017.06.003
   PubMed Web of Science ®Google Scholar
• Wei F, Wang Q, Liu H, et al. High efficacy combined microneedles array with methotrexate nanocrystals for effective anti-rheumatoid arthritis. Int j Nanomed. 2022;17:2397–2412. doi:10.2147/ijn.S365523
   PubMed Web of Science ®Google Scholar
• Aparicio-Blanco J, Sebastián V, Benoit JP, Torres-Suárez AI. Lipid nanocapsules decorated and loaded with cannabidiol as targeted prolonged release carriers for glioma therapy: in vitro screening of critical parameters. Eur J Pharm Biopharm. 2019;134:126–137. doi:10.1016/j.ejpb.2018.11.020
   PubMed Web of Science ®Google Scholar
• Kok LY, Bannigan P, Sanaee F, et al. Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol. Eur J Pharm Sci. 2022:168. doi:10.1016/j.ejps.2021.106058
   Web of Science ®Google Scholar
• Rao Y, Li R, Liu S, et al. Enhanced bioavailability and biosafety of cannabidiol nanomicelles for effective anti-inflammatory therapy. Particuology. 2022;69:1–9. doi:10.1016/j.partic.2021.11.010
   Web of Science ®Google Scholar
• Parmar PK, Wadhawan J, Bansal AK. Pharmaceutical nanocrystals: a promising approach for improved topical drug delivery. Drug Discovery Today. 2021;26(10):2329–2349. doi:10.1016/j.drudis.2021.07.010
   PubMed Web of Science ®Google Scholar
• Pisanti S, Malfitano AM, Ciaglia E, et al. Cannabidiol: state of the art and new challenges for therapeutic applications. Pharmacol Ther. 2017;175:133–150. doi:10.1016/j.pharmthera.2017.02.041
   PubMed Web of Science ®Google Scholar
• Li H, Liu Y, Tian D, et al. Overview of cannabidiol (CBD) and its analogues: structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer’s disease. Eur J Med Chem. 2020:192. doi:10.1016/j.ejmech.2020.112163
   Google Scholar
• Bruni N, Della Pepa C, Oliaro-Bosso S, Pessione E, Gastaldi D, Dosio F. Cannabinoid delivery systems for pain and inflammation treatment. Molecules. 2018;23(10). doi:10.3390/molecules23102478
   Web of Science ®Google Scholar
• Hao F, Feng Y. Cannabidiol (CBD) enhanced the hippocampal immune response and autophagy of APP/PS1 Alzheimer’s mice uncovered by RNA-seq. Life Sci. 2021;264. doi:10.1016/j.lfs.2020.118624
   Web of Science ®Google Scholar
• Nichols JM, Kaplan BLF. Immune responses regulated by cannabidiol. Cannabis Cannabinoid Res. 2020;5(1):12–31. doi:10.1089/can.2018.0073
   PubMedGoogle Scholar
• Malfait AM, Gallily R, Sumariwalla PF, et al. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci. 2000;97(17):9561–9566. doi:10.1073/pnas.160105897
   PubMed Web of Science ®Google Scholar
• Philpott HT, O’Brien M, McDougall JJ. Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis. Pain. 2017;158(12):2442–2451. doi:10.1097/j.pain.0000000000001052
   PubMed Web of Science ®Google Scholar
• Hammell DC, Zhang LP, Ma F, et al. Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis. Eur J Pain. 2016;20(6):936–948. doi:10.1002/ejp.818
   PubMed Web of Science ®Google Scholar
• Lodzki M, Godin B, Rakou L, Mechoulam R, Gallily R, Touitou E. Cannabidiol—transdermal delivery and anti-inflammatory effect in a murine model. J Control Release. 2003;93(3):377–387. doi:10.1016/j.jconrel.2003.09.001
   PubMed Web of Science ®Google Scholar
• Pirrung MC. Synthetic access to cannabidiol and analogs as active pharmaceutical ingredients. J Med Chem. 2020;63(21):12131–12136. doi:10.1021/acs.jmedchem.0c00095
   Web of Science ®Google Scholar
• Pang L, Zhu S, Ma J, et al. Intranasal temperature-sensitive hydrogels of cannabidiol inclusion complex for the treatment of post-traumatic stress disorder. Acta Pharmaceutica Sinica B. 2021;11(7):2031–2047. doi:10.1016/j.apsb.2021.01.014
   Web of Science ®Google Scholar
• Izgelov D, Davidson E, Barasch D, Regev A, Domb AJ, Hoffman A. Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers. Eur J Pharm Biopharm. 2020;154:108–115. doi:10.1016/j.ejpb.2020.06.021
   PubMed Web of Science ®Google Scholar
• Volpe-Zanutto F, Ferreira LT, Permana AD, et al. Artemether and lumefantrine dissolving microneedle patches with improved pharmacokinetic performance and antimalarial efficacy in mice infected with Plasmodium yoelii. J Control Release. 2021;333:298–315. doi:10.1016/j.jconrel.2021.03.036
   PubMed Web of Science ®Google Scholar
• Möschwitzer JP. Drug nanocrystals in the commercial pharmaceutical development process. Int J Pharm. 2013;453(1):142–156. doi:10.1016/j.ijpharm.2012.09.034
   PubMed Web of Science ®Google Scholar
• Wang Q, Yang X, Gu X, et al. Celecoxib nanocrystal-loaded dissolving microneedles with highly efficient for osteoarthritis treatment. Int J Pharm. 2022:625. doi:10.1016/j.ijpharm.2022.122108
   Google Scholar
• Abdelghany S, Tekko IA, Vora L, Larrañeta E, Permana AD, Donnelly RF. Nanosuspension-based dissolving microneedle arrays for intradermal delivery of curcumin. Pharmaceutics. 2019;11(7). doi:10.3390/pharmaceutics11070308
   Web of Science ®Google Scholar
• He M, Yang G, Zhang S, Zhao X, Gao Y. Dissolving microneedles loaded with etonogestrel microcrystal particles for intradermal sustained delivery. J Pharmaceut Sci. 2018;107(4):1037–1045. doi:10.1016/j.xphs.2017.11.013
   PubMed Web of Science ®Google Scholar
• Vora LK, Vavia PR, Larrañeta E, Bell SEJ, Donnelly RF. Novel nanosuspension-based dissolving microneedle arrays for transdermal delivery of a hydrophobic drug. J Interdiscip Nanomed. 2018;3(2):89–101. doi:10.1002/jin2.41
   PubMedGoogle Scholar
• Yu K, Yu X, Cao S, et al. Layered dissolving microneedles as a need-based delivery system to simultaneously alleviate skin and joint lesions in psoriatic arthritis. Acta Pharmaceutica Sinica B. 2021;11(2):505–519. doi:10.1016/j.apsb.2020.08.008
   PubMed Web of Science ®Google Scholar
• Wang B, Zhang S, Yang G, et al. Dissolvable polymeric microneedles loaded with aspirin for antiplatelet aggregation. Asian J Pharm Sci. 2023;18(1). doi:10.1016/j.ajps.2023.100776
   Web of Science ®Google Scholar
• Vargas-Ruiz R, Montiel-Ruiz RM, Herrera-Ruiz M, et al. Effect of phenolic compounds from Oenothera rosea on the kaolin-carrageenan induced arthritis model in mice. J Ethnopharmacol. 2020:253. doi:10.1016/j.jep.2020.112711
   Web of Science ®Google Scholar
• Tuomela A, Hirvonen J, Peltonen L. Stabilizing agents for drug nanocrystals: effect on bioavailability. Pharmaceutics. 2016;8(2). doi:10.3390/pharmaceutics8020016
   Web of Science ®Google Scholar
• Chogale M, Ghodake V, Patravale V. Performance parameters and characterizations of nanocrystals: a brief review. Pharmaceutics. 2016;8(3). doi:10.3390/pharmaceutics8030026
   Web of Science ®Google Scholar
• Bansal V, Demir YK, Akan Z, Kerimoglu O. Characterization of polymeric microneedle arrays for transdermal drug delivery. PLoS One. 2013;8(10). doi:10.1371/journal.pone.0077289
   Web of Science ®Google Scholar
• Li W, Terry RN, Tang J, Feng MR, Schwendeman SP, Prausnitz MR. Rapidly separable microneedle patch for the sustained release of a contraceptive. Nat Biomed Eng. 2019;3(3):220–229. doi:10.1038/s41551-018-0337-4
   PubMed Web of Science ®Google Scholar
• Matarazzo AP, Elisei LMS, Carvalho FC, et al. Mucoadhesive nanostructured lipid carriers as a cannabidiol nasal delivery system for the treatment of neuropathic pain. Eur J Pharm Sci. 2021:159. doi:10.1016/j.ejps.2020.105698
   Web of Science ®Google Scholar
• Tekko IA, Permana AD, Vora L, Hatahet T, McCarthy HO, Donnelly RF. Localised and sustained intradermal delivery of methotrexate using nanocrystal-loaded microneedle arrays: potential for enhanced treatment of psoriasis. Eur J Pharm Sci. 2020;152. doi:10.1016/j.ejps.2020.105469
   Web of Science ®Google Scholar
• Xu C, Chang T, Du Y, Yu C, Tan X, Li X. Pharmacokinetics of oral and intravenous cannabidiol and its antidepressant-like effects in chronic mild stress mouse model. Environ Toxicol Pharmacol. 2019;70. doi:10.1016/j.etap.2019.103202
   Web of Science ®Google Scholar
• Parveen N, Abourehab MAS, Thanikachalam PV, Khar RK, Kesharwani P. Nanocrystals as an emerging nanocarrier for the management of dermatological diseases. Colloids Surf B. 2023;225. doi:10.1016/j.colsurfb.2023.113231
   Web of Science ®Google Scholar
• Verma S, Huey BD, Burgess DJ. Scanning probe microscopy method for nanosuspension stabilizer selection. Langmuir. 2009;25(21):12481–12487. doi:10.1021/la9016432
   Web of Science ®Google Scholar
• Dolenc A, Kristl J, Baumgartner S, Planinsek O. Advantages of celecoxib nanosuspension formulation and transformation into tablets. Int J Pharm. 2009;376(1–2):204–212. doi:10.1016/j.ijpharm.2009.04.038
   PubMedGoogle Scholar
• Cheng AG, Sun WT, Xing MZ, Zhang SH, Gao YH. The hygroscopicity of polymer microneedles on the performance of dissolving behavior for transdermal delivery. Int J Polym Mater Po. 2022;71(1):72–78. doi:10.1080/00914037.2020.1798442
   Web of Science ®Google Scholar
• Zhao X, Zhang S, Yang G, Zhou Z, Gao Y. Exploring trehalose on the release of levonorgestrel from implantable PLGA microneedles. Polymers. 2020;12(1). doi:10.3390/polym12010059
   Web of Science ®Google Scholar
• Zhou Y, Yang L, Lyu Y, et al. Topical delivery of ROS-responsive methotrexate prodrug nanoassemblies by a dissolvable microneedle patch for psoriasis therapy. Int J Nanomed. 2023;18:899–915. doi:10.2147/ijn.S394957
   PubMed Web of Science ®Google Scholar
• Li W, Li S, Fan X, Prausnitz MR. Microneedle patch designs to increase dose administered to human subjects. J Control Release. 2021;339:350–360. doi:10.1016/j.jconrel.2021.09.036
   Web of Science ®Google Scholar
• Paudel KS, Hammell DC, Agu RU, Valiveti S, Stinchcomb AL. Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers. Drug Dev Ind Pharm. 2010;36(9):1088–1097. doi:10.3109/03639041003657295
   PubMed Web of Science ®Google Scholar
• Stinchcomb AL, Valiveti S, Hammell DC, Ramsey DR. Human skin permeation of Δ8-tetrahydrocannabinol, cannabidiol and cannabinol. J Pharm Pharmacol. 2004;56(3):291–297. doi:10.1211/0022357022791
   PubMed Web of Science ®Google Scholar
• Junaid MSA, Tijani AO, Puri A, Banga AK. In vitro percutaneous absorption studies of cannabidiol using human skin: exploring the effect of drug concentration, chemical enhancers, and essential oils. Int J Pharm. 2022;616. doi:10.1016/j.ijpharm.2022.121540
   Google Scholar